Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Grant or award Sr VP, Gen. Counsel, Secretary acquired 71,000 shares (grant or award)
  2. 4 Grant or award SVP, Research & Early Clin Dev acquired 71,000 shares (grant or award)
  3. 4 Grant or award Sr. VP, Technical Operations acquired 64,700 shares (grant or award)
  4. 4 Grant or award Sr VP, Chief Comm. Officer acquired 71,000 shares (grant or award)
  5. 4 Grant or award Sr VP, Chief Financial Officer acquired 71,000 shares (grant or award)
  6. 4 Grant or award Director acquired 6,000 shares (grant or award)
  7. 4 Grant or award Director acquired 6,000 shares (grant or award)
  8. 4 Grant or award Director acquired 6,000 shares (grant or award)
  9. 4 Grant or award Director acquired 6,000 shares (grant or award)
  10. 4 Grant or award Director acquired 6,000 shares (grant or award)
  11. 4 Grant or award Director acquired 6,000 shares (grant or award)
  12. 4 Grant or award Director acquired 6,000 shares (grant or award)
  13. 4 Insider Changes in Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy 10% owner bought 317,770 shares at $8,544,835.30 ($2,715,292,313,281)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 50,225 shares (to pay taxes)
  17. 4 Shares withheld for taxes Sr VP, Gen. Counsel, Secretary gave up 22,833 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, Research & Early Clin Dev gave up 22,833 shares (to pay taxes)
  19. 4 Shares withheld for taxes Sr. VP, Technical Operations gave up 14,650 shares (to pay taxes)
  20. 4 Shares withheld for taxes Sr VP, Chief Comm. Officer gave up 18,849 shares (to pay taxes)

Page 17 of 39 · 776 filings